Fig. 1

Kaplan–Meier estimates of progression free survival (a) and overall survival (b) in the S-1 and DP groups. Kaplan–Meier estimates by completeness of concurrent chemotherapy for progression free survival (c) and overall survival (d) using patients in the DP group